Maple Syrup Urine Disorder (MSUD)

40
Maple Syrup Urine Disorder (MSUD) UPCM Class 2011 Block 9b Tampo, Tanyu, Tiongson, Torio

description

Maple Syrup Urine Disorder (MSUD). UPCM Class 2011 Block 9b Tampo , Tanyu , Tiongson , Torio. This is a case of A.M., a 1 month-old baby boy from Bataan, admitted for the first time in PGH last August 16, 2009 - PowerPoint PPT Presentation

Transcript of Maple Syrup Urine Disorder (MSUD)

Page 1: Maple Syrup Urine Disorder (MSUD)

Maple Syrup Urine Disorder (MSUD)

UPCM Class 2011 Block 9b

Tampo, Tanyu, Tiongson, Torio

Page 2: Maple Syrup Urine Disorder (MSUD)

This is a case of A.M., a 1 month-old baby boy from Bataan, admitted for the first time in PGH last August 16, 2009

With a chief complaint of poor suck

Page 3: Maple Syrup Urine Disorder (MSUD)

CLINICAL HISTORY

Page 4: Maple Syrup Urine Disorder (MSUD)

Birth and Maternal History

• Born full term to a 24 yo G2P1 (1001) mother, • via NSVD at a local hospital in Bataan• Was said to have good activity and good cry• Claimed to have 3 PNCU at a health center• Denied comorbid conditions except UTI-8mos– Treated with Cefalexin x 7 days

• Only 1 UTZ done, result was unrecalled

Page 5: Maple Syrup Urine Disorder (MSUD)

History of Present Illness

• Apparently well until 1st week of life• Noted to have no eye opening and was said to

have stiffening of the upper and lower ex• Consult at local hospital admitted x 7 days• Septic work-up was done, treated and

discharged with a diagnosis of neonatal sepsis

Page 6: Maple Syrup Urine Disorder (MSUD)

• Patient was well until 1 week PTA• Noted to have decreased milk intake with

poor sucking reflex and an episode of apparent apnea

• Consult done and noted bulging fontanelle, admitted at a different hospital for 7 days

• Antibiotics (amikacin, gentamycin) was given

Page 7: Maple Syrup Urine Disorder (MSUD)

• Cranial CT was done revealing a demyelinating disorder

• Lumbar tap done, results unrecalled.• Was referred to PGH

Page 8: Maple Syrup Urine Disorder (MSUD)

Family History

• (+) DM: maternal side, grandmother• (-) HPN, (-)BA, (-)PTB, (-) goiter, (-) cancer• (-) heart, liver, lung diseases• (-) similar conditions in the family

Page 9: Maple Syrup Urine Disorder (MSUD)

Immunization / Nutritional

• No vaccines received yet• Purely breastfed while the baby is well

Page 10: Maple Syrup Urine Disorder (MSUD)

Summary

Page 11: Maple Syrup Urine Disorder (MSUD)

PHYSICAL EXAMINATION

Page 12: Maple Syrup Urine Disorder (MSUD)

Sytemic PE• Normocephalic, open ant/posterior fontanelle, no bulging

fontanelle• Warm skin, slightly pale, (-) rashes, CRT <2secs, good turgor• Non bulging eyes, still unable to open eyes, slightly swelled

lids• (-) ear discharge, supple neck• ECE, (-) retractions, CBS]• AP, RR, (-) murmur• Globular, NABS, soft, (-) organomegaly, liver edge palpable

1 fingerbreadth below costal margin• (-) phimosis, descended testis (bilateral)• Grossly normal extremities

Page 13: Maple Syrup Urine Disorder (MSUD)

Neurologic Exam

• Asleep, cries to painful stimuli but no eye opening

• (-) neck rigidity, (+) babinski• CN: no facial assymetry• Motor: moves all extremity spontaneously• Sensory: withdraws to pain• DTR: 2+ uppers and lowers• Reflex: (+) grasp, moro, rooting

Page 14: Maple Syrup Urine Disorder (MSUD)

COURSE IN THE HOSPITAL

Page 15: Maple Syrup Urine Disorder (MSUD)

Day 1 (8/16/09)• Patient was admitted at Pedia ER on August 16, 2009• S/O>

– 2.4 kg, febrile, (+) sweet odor of urine, – (+) 2 ketones in urine

• A> – neonatal sepsis, hospital acquired – t/c inborn error of metabolism (MSUD)

• P>– NPO, IVF (FM) 240cc/hr, O2 support done– Dx:

• CBC, BT, electrolytes, Blood CS, CXR PAL, UA with ketones– Tx:

• meropenem (120) 96 mg IV q8• Amikacin (15) 40 mg IV OD

Page 16: Maple Syrup Urine Disorder (MSUD)

Day 2 (8/17/09)• Seen by Neuro due to seizures

– A> • Hospital acquired sepsis• t/c IEM (MSUD)

– P>• Continue meds• IVF

– 1) D12.5IMB– 2) start intralipid 20% solution (2g/kg/day)

• Seen by Genetics– Leucine level 4300, facilitate PD

• Referrals– Pedia Surg: for Catheter insertion for PD– Renal: for Catheter insertion

Page 17: Maple Syrup Urine Disorder (MSUD)

Day 2 (8/17/09)

• Admitted at Ward 9 Bed 9• TFI 175 [1] D12.5IMB (FM) , [2] intralipid (1)

• For FFP transfusion – Plt 14.8– PT 12.2 / 22.0 / 0.40 / 2.10– PTT 34.6 / 72.3

• t/s vitamin K

Page 18: Maple Syrup Urine Disorder (MSUD)

Day 3 (8/18/09)

• s/p Tenckhoff Catheter insertion, Right EJ cutdown

• Tx: meropenem, amikacin, vit K• IVF: D12.5IMB, intralipid via face mask

• O2 support via via face mask

Page 19: Maple Syrup Urine Disorder (MSUD)

PROBLEM LIST

Page 20: Maple Syrup Urine Disorder (MSUD)

Fluids

• S/O> patient on OGT, probable acute phase of MSUD

• A> maintain appropriate hydration and caloric intake

• P> continue IVF • 1] D12.5IMB

• 2] intralipid

Page 21: Maple Syrup Urine Disorder (MSUD)

Others

• S/O> still unable to spontaneously open eyes, slight swelling or upper lids, (-) discharge, (-) redness

• A> swollen lids• P> referral to Ophthalmology

Page 22: Maple Syrup Urine Disorder (MSUD)

Respiratory

• S/O> s/p catheter insertion• A> supportive oxygen administration• P> – continue O2 support via face mask

– To watch out for respiratory distress

Page 23: Maple Syrup Urine Disorder (MSUD)

Infection

• S/O> blood culture (+) Enterobacter• A> Hospital Acquired sepsis• P> continue meds– Meropenem– Amikacin

Page 24: Maple Syrup Urine Disorder (MSUD)

Cardiac

• S/O> AP, regular rhythm, HR 102, (-) murmurs• A> no cardiac disorder at the moment• P> none for now

Page 25: Maple Syrup Urine Disorder (MSUD)

Hematologic

• S/O> – Plt 14.8– PT 12.2 / 22.0 / 0.40 / 2.10– PTT 34.6 / 72.3

• A> thrombocytopenia• P> – Continue vit K– Repeat CBC, PT/PTT

Page 26: Maple Syrup Urine Disorder (MSUD)

Metabolic

• S/O> (+) sweet urine odor, (+) urine ketones• A> t/c MSUD• P> continue PD

Page 27: Maple Syrup Urine Disorder (MSUD)

Neurologic

• S/O> (+) episodes of seizure-like activity• A> seizure prob 2 to MSUD,or hypoglycemia• P> – standby diazepam at bedside– Monitor Hgt

Page 28: Maple Syrup Urine Disorder (MSUD)

Developmental

• S/O> (+) MSUD• A> mental and neurologic deficits are

common sequelae• P> – regular follow-up at a Pediatric clinic – Watch out for infection

Page 29: Maple Syrup Urine Disorder (MSUD)

MAPLE SYRUP URINE DISEASE

Page 30: Maple Syrup Urine Disorder (MSUD)

Branched Chain Amino Acids

Isoleucine Valine Leucine

Page 31: Maple Syrup Urine Disorder (MSUD)

Catabolism

• Transamination• Oxidative Decarboxylation*• Dehydrogenation• End products

* Enzyme responsible: Branched-chain α-ketoacid dehydrogenase

Page 32: Maple Syrup Urine Disorder (MSUD)

Branched-chain α-ketoacid dehydrogenase

• A complex enzyme system using tyrosine pyrophosphate (Vit B1) as coenzyme

• A mitochondrial enzyme consisting of four subunits E1α, E1β, E2, E3

• Deficiency of this ensyme causes Maple Syrup Urine Disease (MSUD)

Page 33: Maple Syrup Urine Disorder (MSUD)

MSUD

• Named after sweet odor of maple syrup found in body fluids, esp. urine

• 5 phenotypes have been identified based on clinical findings and response to thiamine– 1. Classic MSUD– 2. Intermittent MSUD– 3. Mild (Intermediate) MSUD– 4. Thiamine-responsive MSUD– 5. MSUD due to deficiency in E3 subunit

Page 34: Maple Syrup Urine Disorder (MSUD)

Classic MSUD

• Clinical:– 1st week: poor feeding and vomiting lethargy

coma– Convulsions occur in most infants– Labs: metabolic acidosis

Page 35: Maple Syrup Urine Disorder (MSUD)

Classic MSUD• Diagnosis:– Definitive: Amino acid analysis shows ↑ leucine,

isoleucine, valine– Peculiar odor of maple syrup in urine, sweat, and

cerumen– Urine: (+) amino acids and their respective ketoacids– Qualitative test:

• Add 2,4-dinitrophenylhydrazine reagent (0.1% in 0.1 N HCl) to urine

• Formation of a yellow precipitate (2,4-dihydrophenylhydrazone) yields a positive test

– Hypomyelination may be seen in neuroimaging

Page 36: Maple Syrup Urine Disorder (MSUD)

Classic MSUD

• Treatment:– In acute phase:• Adequate hydration• Quick removal of metabolites via Peritoneal Dialysis• Response: significant ↓plasma levels w/n 24 hrs• May develop cerebral edema, treated with mannitol

– After acute phase:• Diet low on branched chain amino acids• Remain on diet for the rest of their lives• Liver transplant shows promising results

Page 37: Maple Syrup Urine Disorder (MSUD)

Classic MSUD

• Prognosis:– Prognosis remains guarded– May develop the following in stressful conditions

(infection/surgery)• Severe ketoacidosis, cerebral edema, death

– Mental and neurologic deficits are common sequelae

Page 38: Maple Syrup Urine Disorder (MSUD)

Genetics of MSUD

• Autosomal recessive• Prevalence of 1 / 185,000• Classic form is more prevalent

Page 39: Maple Syrup Urine Disorder (MSUD)

LABORATORIES

Page 40: Maple Syrup Urine Disorder (MSUD)

CBC

• Hgb: 99• Hct: 0.282• WBC: 3.99– Segmenters: 0.46– Monocytes: 0.15– Eosinophils: 0.003– Lypmhocytes: 0.003– Basophils: 0.374

• Plt: 14.8